Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2

21 Feb 2023

Abstract excerpt

The COVID-19 pandemic has spread worldwide, and rapid detection of the SARS-CoV-2 virus is crucial for infection surveillance and epidemic control. This study developed a centrifugal microfluidics-based multiplex reverse transcription recombinase polymerase amplification (RT-RPA) assay for endpoint fluorescence detection of the E, N, and ORF1ab genes of SARS-CoV-2. The microscope slide-shaped microfluidic chip...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to Biosensors and Analytical Detection
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36845031
DOI: 10.1016/j.isci.2023.106245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Centrifugal microfluidic-based multiplex recombinase polymerase amplification assay for rapid detection of SARS-CoV-2PMID 36845031Read ↗

A microfluidic-integrated lateral flow recombinase polymerase amplification (MI-IF-RPA) assay for rapid COVID-19 detectionSemantic proximity Read ↗

Rapid Differential Diagnosis of Influenza A and B Viruses With RT‐RPA Centrifugal Microfluidic ChipSemantic proximity Read ↗

Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation SequencingSemantic proximity Read ↗

Microfluidic chip and isothermal amplification technologies for the detection of pathogenic nucleic acidSemantic proximity Read ↗

Microfluidic Nano-Scale qPCR Enables Ultra-Sensitive and Quantitative Detection of SARS-CoV-2Semantic proximity Read ↗

Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assaySemantic proximity Read ↗

Detection and identification of SARS-CoV-2 and influenza a based on microfluidic technologySemantic proximity Read ↗

Development of a colorimetric RT-LAMP-based microfluidic device for COVID-19 diagnosisSemantic proximity Read ↗

Advances in Nucleic Acid Assays for Infectious Disease: The Role of Microfluidic TechnologySemantic proximity Read ↗

Rapid High Throughput Whole Genome Sequencing of SARS-CoV-2 by using One-step RT-PCR Amplification with Integrated Microfluidic System and Next-Gen SequencingSemantic proximity Read ↗

Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplificationSemantic proximity Read ↗

All-in-One Microfluidic Chip for the Point-of-Care-Testing of Nucleic Acids: Combining a Dynamic-Seal Microvalve, Ultrasound-Assisted Reaction Chamber, and Slice Amplification with a Fluorescence Detection SystemSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.